mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.04 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.05 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.05 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.05 |
mRNA |
simvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.05 |